Chi-Yin Liao

SEP 8, 2026 · JOURNAL ARTICLE

Bridging Biomarker Testing to Biomarker-Driven Targeted Therapy: Real-World ESR1 Mutation Testing Patterns and Prevalence in ER+, HER2− Metastatic Breast Cancer

Molecular Diagnosis & Therapy

Real-world observational study reporting descriptive testing patterns and mutation prevalence without a comparator or causal inference; provides practice-relevant epidemiology but limited mechanistic or interventional evidence.